Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Yusuf Omosun

Yusuf Omosun

Morehouse School of Medicine USA

Francis Eko

Francis Eko

Morehouse School of Medicine USA

Giulio Tarro

Giulio Tarro

Foundation de Beaumont Bonelli for Cancer Research Italy

Imran Saleem

Imran Saleem

Liverpool John Moores University UK

Erwann Loret

Erwann Loret

Aix-Marseille University France

Talin Barissani-Asenbauer

Talin Barissani-Asenbauer

Medical University of Vienna Austria

Rainer Henning

Rainer Henning

Viravaxx AG Austria

Lallan Giri

Lallan Giri

Biologic Resources LLC USA

Vaccines Summit 2018

About Conference

ConferenceSeries Ltd looks forward to welcome all the participants across the world to attend "29th International Conference on Vaccines and Immunization" during March 19-20, 2018 in London, UK. The conference highlights the theme “Highlights of latest technologies and innovations in Vaccines and Immunization”.

Following the great success of the 19th International Conference on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany, ConferenceSeries Ltd is organizing the 29th International Conference on Vaccines and ImmunizationMarch 19-20, 2018 London, UK. This will be one of the best in the ConferenceSeries Ltd annual vaccine meeting series with 300 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccines Summit 2018 is aimed to give an opportunity that with scholars from around the world focused on learning about Vaccines & Immunology and its advances; this is the best opportunity to reach the largest assemblage of participants from the Vaccines & Immunology community. It provide an explicit platform for presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines & Immunology are hallmarks of this conference.

Target Audience:

  • Researchers & Scientists related to Vaccine R&D
  • Deans and Professors
  • Directors, CEOs, Presidents and Vice Presidents
  • University Faculty
  • Medical Schools/Colleges
  • Nursing Schools/Colleges
  • Associations and Societies related to Vaccine R&D
  • Vaccination Programme Organising Government and Non-government Organisations
  • Business Entrepreneurs
  • Medical Devices Manufacturing Companies
  • Vaccine Manufacturing Companies
  • Vaccine Developers and Investigators

 

Sessions/Tracks

Conferenceseries is organizing "29th International Conference on Vaccines and Immunization" during March 19-20, 2018 in London, UK, which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Vaccines Summit 2018 features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics.

Vaccines Summit 2018 conference aims to promote and share knowledge on current research & production of vaccines. The conference gathers Immunology specialists, Scientists, Professors and research faculty from academia, Clinical, Veterinary, Medical, CEO’s, Presidents, Policy makers, Professionals from regulatory agencies, Public health professionals, Business delegates of vaccines, Value Chain community of the vaccines with the following profession areas: Innovators, Disruptors, and Influencers, Post doc and PhD students in allied disciplines across the globe under a single roof gather in Phoenix to speak on current research and future strategies for development and production of vaccine.

Track 1: Human Vaccines against Infectious Diseases

Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical. The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 2: Cancer, Malaria & TB Vaccines

Therapeutic cancer vaccines are administrated to cancer patients to eradicate cancer cells through strengthening patient's own immune responses. The various immune effector mechanisms of therapeutic vaccination i.e. it specifically attack and destroy cancer cells and spare normal cells. Thus cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumours that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. Despite of many decades of intense research and development, there is no commercially available malaria vaccine till today. RTS,S/AS01 is the most advanced vaccines candidate against the most deadly human malariaP. falciparum. More than 20 other vaccine constructed are currently in clinical trials or are in advanced preclinical development. BCG is the only available TB vaccines. But, BCG is partially effective as it provides protection only against severe forms of paediatric TB, not completely protective against infants and adult pulmonary TB. Therefore there is an urgent need for new, safe and effective vaccines that prevent against all forms of TB.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands..

Track 3: HIV Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A preventive vaccine would stop HIV infection occurring altogether, whereas a therapeutic vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV. 
 

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 4: Immunizations & Bioterrorism

Bioweapons threat could include the deliberate release of a biological agent by attackers that causes one or more variety of different diseases. The use of effective vaccines would likely to protect lives and limit disease spread in a biological weapons emergency. Licensed vaccines are currently available for a few threats, such as anthrax and smallpox, and research is underway to develop and produce vaccines for other threats, such as tularaemia, Ebola virus, and Marburg virus. Many bioweapon disease threats, however, lack a corresponding vaccine, and for those that do, significant challenges exist to their successful use in an emergency situation.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 5: Combination and Conjugate Vaccines

Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections doesn’t increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 6: DNA & Synthetic Vaccines

Scientists take many approaches to designing vaccines against a microbe. These choices are typically based on fundamental information about the microbe, such as how it infects cells and how the immune system responds to it, as well as practical considerations, such as regions of the world where the vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. In addition, DNA vaccines are relatively easy and inexpensive to design and produce. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either. Fractional vaccines are either protein-based or polysaccharide-based.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 7: Travel & Edible Vaccines

Travel vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travellers and to prevent disease spread within and between countries. There is no single vaccination schedule that fits all travellers. Each schedule must be individualized according to the traveller’s previous immunizations, health status and risk factors, the countries to be visited, the type and duration of travel, and the amount of time available before departure. 

Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and sociocultural readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 8: Paediatric Vaccination

Immunization against diseases such as Polio, Tetanus, Diphtheria, and Pertussis saves the lives of approximately three million children each year. Immunization also prevents many more millions from suffering debilitating illness and lifelong disability. Globally, approximately 132 million babies need to be fully immunized each year. In order to meet this need, immunization systems must have adequate resources, trained and motivated staff, and ample vaccines and syringe supplies.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 9: Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination. 

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 10Veterinary Vaccines

Considerable progress has been made in the production of veterinary vaccines whether live or inactivated for animal use during the past two decades with the increasing use of continuous cell lines as a substrate and adoption of the fermentor technology for antigen production. These vaccines are produced for administration to domestic animals or wild species by parenteral or oral routes according to vaccine characteristics. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parentally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA. Trials are under way for the oral immunization of dogs in developing countries.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 11: Fish & Poultry Vaccines

Vaccines developed for aquaculture have reduced antibiotic use in fish production. Currently, vaccines are available for some economically important bacterial and only few vaccines for viral diseases and no vaccine developed for fish parasites and fungus. Major limitations in fish vaccine developments are less understanding of fish immunology, many vaccines unlicensed, not cost effective (expensive) and stressful on administration. Research are needed to review on the present status of fish vaccination for controlling fish diseases, and shows the needs and directions for future investigations.

Vaccination plays an important part in the health management of the poultry flock. There are numerous diseases that are prevented by vaccinating the birds against them. A vaccine helps to prevent a particular disease by triggering or boosting the bird’s immune system to produce antibodies that in turn fight the invading causal organisms.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 12: Vaccines against Drugs

Drug addiction is a serious problem worldwide. One therapy being investigated is vaccines against drugs of abuse. The antibodies elicited against the drug can take up the drug and prevent it from reaching the reward centres in the brain. Few such vaccines have entered clinical trials, but research is going on apace. Many studies are very promising and more clinical trials should be coming out in the near future.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 13: Vaccines & Autism

Vaccinations may be one of the triggers for autism. Substantial data demonstrate immune abnormality in many autistic children consistent with impaired resistance to infection, activation of inflammatory response, and autoimmunity. Impaired resistance may predispose to vaccine injury in autism. A mercurial preservative in childhood vaccines, thimerosal, may cause direct neurotoxic, immune-depressive, and autoimmune injury and contribute to early-onset and regressed autism. Live viruses in measles, mumps, and rubella (MMR) may result in chronic infection of the gut and trigger regressed autism. Thimerosal injection may potentiate MMR injury.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 14: Vaccine Safety and Efficacy

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 15: Geriatric Immunization

As we get older, our immune system tends to weaken over time, putting us at higher risk for certain diseases. This is why, in addition to seasonal flu (influenza) vaccine and Td or Tdap vaccine (tetanus, diphtheria, and pertussis), the adults 60 years or older should take Pneumococcal vaccines, which protect against pneumococcal disease, including infections in the lungs and bloodstream (also recommended for adults younger than 65 years who have certain chronic health conditions) and Zoster vaccine, which protects against shingles.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 16: Vaccines for Pregnant women and Neonates

Immunization during pregnancy has the potential to protect the mother and the infant against vaccine preventable diseases. New born infants are at high-risk for significant illness and death from certain infectious diseases because their immune system has not fully developed. One aim of vaccinating pregnant women is to increase the amount of maternal antibody (proteins that fight disease) transferred to infants, potentially protecting them from infectious disease

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 17: Vaccines for Unconventional Diseases

It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional indications. These vaccines have been in most cases developed so far as treatment vaccines. This is in opposite to infectious diseases vaccines used as prophylactic vaccines. Despite promising late stage candidates, with some very recent failures, there is still no antibody-inducing vaccine approved targeting other than microorganism antigens (i. e targeting self-antigens , addiction molecules antigens and others. It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional diseases.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017  Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The  Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

 Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 18: Animal Models and Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 19: Animal & Plant Derived Vaccines

It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using plant engineering, there are some difficulties in reaching the final goal: to manufacture an approved product. At present, the only plant-made vaccine approved by the United States Department of Agriculture is a Newcastle disease vaccine for poultry that is produced in suspension-cultured tobacco cells. The progress toward commercialization of plant-based vaccines takes much effort and time, but several candidate vaccines for use in humans and animals are in clinical trials. This review discusses plant engineering technologies and regulations relevant to the development of plant-based vaccines and provides an overview of human and animal vaccines currently under clinical trials.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 20: Vectors, Adjuvants & Delivery Systems

vaccine adjuvant is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccine ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 21: Vaccine Production & Development

Vaccine development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 22: Cellular Immunology and Latest Innovations

The response to pathogens is composed by the complex interactions and activities of the large number of diverse cell types involved in the immune response. The innate immune response is the first line of defence and occurs soon after pathogen exposure. It is carried out by phagocytic cells such as neutrophils and macrophages, cytotoxic natural killer (NK) cells, and granulocytes. The subsequent adaptive immune response includes antigen-specific defence mechanisms and may take days to develop. Cell types with critical roles in adaptive immunity are antigen-presenting cells including macrophages and dendritic cells. Antigen-dependent stimulation of various cell types including T cell subsets, B cells, and macrophages all play critical roles in host defence.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 23: Antibodies Engineering and Therapeutics

Antibodies, also called immunoglobulins, are large Y-shaped proteins which function to identify and help remove foreign antigens or targets such as viruses and bacteria. Antibodies are produced by specialized white blood cells called B lymphocytes (or B cells). When an antigen binds to the B-cell surface, it stimulates the B cell to divide and mature into a group of identical cells called a clone. The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and lymphatic system. Every different antibody recognizes a specific foreign antigen. This is because the two tips of its “Y” are specific to each antigen, allowing different antibodies to bind to different foreign antigens. Antibodies are produced by the immune system in response to the presence of an antigen. Antibody engineering has become a well-developed discipline, encompassing discovery methods, production strategies, and modification techniques that have brought forth clinically investigated and marketed therapeutics. The realization of the long-standing goal of production of fully human monoclonal antibodies has focused intensive research on the clinical employment of this potent drug category.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Track 24: Current Research & Future Challenges

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

Related: Vaccines Conferences | Immunology Conferences | World Vaccines Congress

29th international conference on Vaccines and immunization March 19-20, 2018, London, UK; 15th Annual Summit on Vaccines and Immunization, February 20-21, 2017 Germany; 17th International Conference on Children Vaccines, August 21-22, 2017 UK; 18th Global Summit & Expo on Vaccines & Vaccination September 18-19, 2017 Houston, USA; 20th Asia Pacific Global Summit and Expo on Vaccines & Vaccination October 5-7, 2017,  Kuala Lumpur, Malaysia; World Vaccine Congress , April 10 - 12, 2017 Washington USA; International Conference on Vaccines, February 20-22, 2017  USA; 19th International Conference on Vaccines and Immunization, June 25 - 26, 2017 France; 30th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 USA; The Florida Immunization Summit, February 2-4, 2017 Florida  USA; HIV Vaccines, March 26-30, 2017 USA; SVS 2017 – Skin Vaccination Summit, 22-24 May 2017 The Netherlands; IVW 2017 – Influenza Vaccines for the World, April 19-21, 2017 Switzerland. 

Related Societies:

European Society for Paediatric Infectious Diseases, Switzerland; European Union Geriatric Medicine Society, Austria; The Anti-Vaccination Society of America, Philadelphia; Infectious Diseases Society of America, Virginia; Association of Immunization Managers, Maryland; International Society of Vaccines, France; European Federation of Immunological Societies, Italy; European Academy of Allergy and Clinical Immunology, Switzerland; The American Association of Immunologists, USA; Clinical Immunology Society, Wisconsin; British Society for Immunology, London; The Federation of Clinical Immunology Societies, Wisconsin; International Union of Immunological Societies, Germany; American Society for Microbiology, USA; Microbiology Society, London; Society for Applied Microbiology, London; European Society of Clinical Microbiology and Infectious Diseases, Switzerland; Swiss Society for Microbiology, Switzerland; Federation of European Microbiological Societies, Netherlands.

Market Analysis

29th International Conference on Vaccines and Immunization

Theme: Highlights of latest technologies and innovations in Vaccines and Immunization

Immunization/Vaccination is a major pasture in eradication of diseases. Conventional approaches to vaccine draft were to enfeeble the human pathogen, Vaccinology is the science of vaccine evolution and how the immune system responds to vaccines, and additionally it includes perpetual workup of Immunization programs, vaccine safety and its efficacy.

Vaccination is important and effective way of preventing infectious disease. That is why majority of countries in the world adopted in second half of the twentieth century to implement various immunization programs. Effectiveness of vaccination is unambiguously proven by regression up-to clearance of many diseases preventable by vaccination. Influence of vaccination can be best illustrated on eradication of smallpox in the world. Thanks to vaccination this deadly disease was overcome, in seventies of the last century this disease was the cause of many deaths. In countries with low immunization rate, i.e. with not adequate collective immunity, many vaccination preventable diseases occur.

 Vaccines Summit 2018 piles up all the Researchers and Healthcare professionals under one roof of to talk on the current research/public health programs and their scientific progress.

Importance & Scope:

Conference series invites all professionals around the world to attend “29th International Conference on Vaccines and Immunization” features with theme "Highlights of latest technologies and innovations in Vaccines and Immunization" on March 19-20, 2018 in London, UK. This conference brings a novel and International compound of massive and form cognizance on vaccines and vaccination, leading universities stir up the conference, an ideal dais to quantify out proficiency, enrich collaborations across trade and world, and assess upgrading technologies across the world.

For more Details: vaccines-immunization.conferenceseries.com

Why London?

London is the capital and most populous city of England and the United Kingdom. London is a leading global city, in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism, and transport. It is one of the world’s leading financial centres and has the fifth- or sixth-largest metropolitan area GDP in the world.

This City is the world cultural capital. It is the world’s most-visited city as measured by international arrivals and has the world’s largest city airport system measured by passenger traffic. London’s universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. According to the report London also ranks first in the world in software, multimedia development and design, and shares first position in technology readiness.

This city has the greatest concentration of top class universities in the world and its international student population of around 110,000 is larger than any other city in the world. London is home to five major medical schools – Barts and The London School of Medicine and Dentistry, King’s College London School of Medicine (the largest medical school in Europe), Imperial College School of Medicine, UCL Medical School and St George’s, University of London – and has a large number of affiliated teaching hospitals. It is also a major centre for biomedical research, and three of the UK’s eight academic health science centres are based in the city – Imperial College Healthcare, King’s Health Partners and UCL Partners (the largest such centre in Europe).

The presence of universities, hospitals, labs and other professional services, together with key installations of the U.K. make it favourite destination for scientific meetings.

 

Major Hospitals

London

United Kingdom

Worldwide

Barts Health NHS Trust

Addenbrooke's Hospital

Stanford Hospitals and Clinics

Barts Health NHS Trust

King's Mill Hospital

Oxford Medical School

Evelina Children's Hospital - St Thomas' Hospital

Nottingham University Hospitals

Mayo Clinic Scottsdale AZ

Royal London Hospital

St Thomas' Hospital

University of Maryland Medical Center

St Mary's Hospital

Papworth Hospital

University of Texas Cancer Centre

St. George's Hospital, London

Royal Devon and Exeter Hospital

Harvard Medical School

The Institute of Cancer Research

King's College Hospital

Cleveland Clinic

 

 

Major Vaccines Associations and Societies

London

Europe

Worldwide

Vaccine Research Association

 

European Federation of Immunological societies (EFIS)

The International Union of Immunological Societies

Italian Society of Allergy, Asthma and Clinical Immunology

The Society for Mucosal Immunology

British Society for Immunology

German Society for Allergology and Clinical Immunology

British Society for Immunology

British Society of Allergy and Clinical Immunology

Federation of African Immunological Societies

Child Health and Society

French Society of Allergology and Clinical Immunology

Federation of Clinical Immunology Societies

Dutch Society of Allergology

Infectious Diseases Society of America

British Global and Travel Health Association

Romanian Society of Allergology and Clinical Immunology

Immune Deficiency Foundation

Czech Society of Allergology and Clinical Immunology

European Federation of Immunological Societies

 

 

Industries Associated with Vaccines

London

United Kingdom

Worldwide

Cambridge Healthcare Supplies Ltd

GlaxoSmithKline

MSD (Merck)

DiscoveRx

AstraZeneca (Med Immune)

Pfizer

Novartis

Pfizer UK

Vaxon Biotech

Parexel

Oxford BioMedica

Sanofi

Praxisb Unico

Vectura Group

Sinovac Biotech

The Binding Site

Proximagen

Vaxxas Nanopatch

The Jenner Institute

Hikma Pharmaceuticals

Antitope (Abzena)

Treos Bio

AAH Pharmaceuticals

GlaxoSmithKline

 

 

Universities Associated with Vaccine Research

London

United Kingdom

Worldwide

Aston University

Heriot-Watt University

Stanford University

Kingston University 

Kingston University 

The University of Sydney

London City University

Surrey Clinical Research Centre

University of Cambridge

Newman University

University College London

Johns Hopkins University

University of London

Oxford University

Harvard University

University of Oxford

University of East Anglia

University of California

University of Alabama

St George's University of London

University of Oxford

 

 

 

 

 

 

 

 

 

 

 

 

Market Value and Market Growth on Vaccines Research in the Past and Upcoming 10 Years:

The global vaccine market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years.

According to a new report released by Transparency Market Research, the value of the global human vaccines market is expected to grow from a $28.3 billion in 2015 to $72.5 billion in 2024. The projection would represent a compound annual growth rate (CAGR) of 11.2% from 2016 to 2024. Even though the dollar figure is large and growing, vaccines still only account 3% of the market share within the global pharmaceutical industry. The report broke down expectations by segments. By age group, paediatric vaccines accounted for 57.5% of the share in 2015, but adult vaccines are expected to grow at a 13.2% CAGR during the forecast period. When the research group analysed the market by product, they found the pneumococcal segment to have the majority share in 2015, but expect hepatitis products to demonstrate strong growth through 2024. By vaccine type, the conjugate vaccines held the majority share in 2015, but the combination vaccines were expected to have the largest CAGR.

Estimated Impact of Immunization on Vaccines Preventable Diseases (WHO Report):

Funding for Vaccines Research:

United Kingdom:

In 2007, the Medical Research Council reviewed its vaccine research portfolio and concluded that it needed to strengthen its translational research by accelerating basic vaccine research into product development and clinical practice and using vaccine research to inform immunisation policies. Five projects have received funding, including a study to monitor the effectiveness of HPV vaccines in teenage girls. There are some academic centres which focus on vaccine research. Some, such as the Jenner Institute in Oxford, specialise in researching novel candidate vaccines. The limiting step for such institutes is the expense of producing batches of novel vaccines and testing them in clinical trials. In 2005, in an effort to encourage UK based pharmaceutical manufacture (including vaccines) the government invested £30m in establishing a National Bio-manufacturing Centre. This facility can produce a wide variety of biopharmaceuticals (including vaccines) under contract from the private sector and academia.

Global Funds:

·         United Nations Children’s Fund (UNICEF)

·         Centre for Disease Control and Prevention (CDC)

·         Bill and Melinda Gates Foundation

·         American Academy of Paediatrics (AAP)

·         Vaccine Foundation (V Foundation)

·         Rockefeller Foundation (RF)

·         National Institute of Health (NIH)

·         Children’s Vaccine Initiative (CVI)

·         Global Alliance for Vaccines and Immunization (GAVI)

Top 10 pharmaceutical companies based on global vaccine revenues in 2015 and 2022 (in million U.S. dollars):

Target Audience:

The conference discusses the latest research outcomes and technological advancements in the field and brings together leading Paediatrics, Immunologists, Physicians, Research Scholars, Students along with Industrial and Vaccines Research professionals to exchange share their views on critical aspects of Vaccines research. The event is designed in a way to provide an exclusive platform for new researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Vaccination. Vaccines summit 2018 will comprise leading keynote speakers, session speakers, poster presenters who will be presenting their research on the topics Human Vaccines Against Infectious Diseases, Cancer, Malaria and TB Vaccines, Immunizations and Bioterrorism, Combination and Conjugate Vaccines, DNA and Synthetic Vaccines, Live, Attenuated, Inactivated and Subunit Vaccines, Travel and Edible vaccines, Paediatric Vaccination, Vaccines for Immune mediated Diseases, Veterinary Vaccines, Vaccines against drugs‎, Vaccines and Autism, Vaccine Safety and Efficacy, Geriatric Immunization, Vaccines for Pregnant women and Neonates, Immunology and Animal Models, Animal and Plant Derived Vaccines, Vectors, Adjuvants and Delivery Systems, Vaccines for unconventional diseases, Cellular Immunology and Latest Innovations, Clinical Immunology & Cancer Immunotherapy, Molecular and Structural Immunology, Antibodies: Engineering and Therapeutics, Regulatory, Societal and Legislation Aspects of Vaccines etc.

Projections:

The global market for vaccines has reported an impressive development in its market valuation, thanks to the increasing rate of birth globally. The rising incidence of diseases such as polio, influenza, hepatitis has also fuelled demand from the global paediatric vaccines market to a great extent.

The vaccines segment dominates the global vaccine products market. The market for live attenuated vaccines has registered the highest growth among all the segments, based on technology. By diseases, the infectious diseases segment has occupied the leading position at present. However, the rising prevalence of cancer, specifically Leukaemia, in kids is projected to register the fastest growth in this market in the coming years. This will further boost the global market for vaccines in the near future. 

North America leads the global market for vaccines and is closely followed by Europe. However, the market for vaccines in Asia Pacific is likely to report the fastest growth during the period from 2012 to 2018 owing to the high birth rate in China and India.

Though the growth prospects for the global market for vaccines looks lucrative, low accessibility to vaccines in developing economies, together with strict regulations for the usage of these vaccines, is likely to hamper the growth of this market over the next few years.

Past Conference Report

Vaccines Summit 2017

The 15th Annual Summit on Vaccines and Immunization (Vaccines Summit 2017) hosted by Conference Series LLC took place at Berlin, Germany during February 20-21, 2017. It was organized by Conference Series LLC and generous response was received from the Editorial Board Members of Conference Series LLC Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2017 from Conference Series LLC. The two day program witnessed thought provoking keynote and plenary presentations from experts in the field of Vaccines and Immunization, highlighting the theme, Discussion on Novel research technologies and practical challenges in Vaccination".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Bacterial and Viral Vaccines
  • Vaccines Against infectious diseases
  • Cancer Vaccines
  • DNA, Protein and Toxoid Vaccines
  • Combination and Conjugate Vaccines
  • Travel and Edible vaccines
  • Malaria and TB Vaccines
  • Hepatitis, HIV and STD Vaccines
  • Pediatric Vaccination
  • Vaccines for Immune mediated Diseases
  • Vaccination for Emerging and Re-emerging diseases
  • Vaccine production and delivery technologies
  • Vaccine Safety and Efficacy
  • Vaccines Industry & Manufacturing
  • Geriatric Immunization
  • Vaccines for unconventional diseases
  • Animal and Plant Derived Vaccines
  • Vaccines for Pregnant women and Neonates
  • Animal Models and Clinical Trials
  • Cellular Immunology and Latest Innovations
  • Clinical Immunology & Cancer Immunotherapy
  • Molecular and Structural Immunology
  • Antibodies : Engineering and Therapeutics

The highlights of the meeting were the eponymic keynote lectures from

  • Giulio Tarro, Foundation de Beaumont Bonelli for Cancer Research, Italy
  • Francis Eko, Morehouse School of MedicineUSA
  • Lallan Giri, Biologics Resources LLC, USA
  • Yusuf Omosun, Morehouse School of Medicine, USA
  • Imran Saleem, Liverpool John Moores University, UK
  • Gustavo Cabral de Miranda, University of Oxford, UK

Vaccines Summit 2017 played an important role in promoting multidisciplinary interactions between Science and Medicine to enhance research in Vaccines and Immunization. The program covered current and emerging research innovations in the field of Vaccines and Immunology.

We would specially thank the Moderator of the Giulio Tarro, Foundation de Beaumont Bonelli for Cancer Research, Italy, for his contribution for the conference.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Vaccines Summit 2017 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series LLC would like to announce the commencement of “29th Annual Summit on Vaccines and Immunization"on March 19-20, 2018 at London, UK.

Let us meet again @ Vaccines Summit 2018

 


Past Reports  Proceedings  Gallery  

Supported By

Journal of Vaccines & Vaccination Journal of Clinical & Cellular Immunology Immunome Research

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by